IGHA1 and nasal cavity polyp: Thus the putative anti-SEE IgEs 1G2 and 203 in patients HPK_014 and HPK_016, together with the potential IgG4 or IgA1 precursors, could have activated a variety of effector cells and contribute to the proinflammatory environment in the patients' nasal polyps.